Prof. Dr. Miriam Erlacher
Experimental hematopoiesis, leukemogenesis, bone marrow failure, MDS, genetic predisposition and cell death signaling
| Since 2023 | Chair of the German MDS study group (within the European Working Group of MDS in childhood; EWOG-MDS), elected by the German Society for Pediatric Oncology/Hematology (GPOH) |
| 2019-2024 | Head of the NAMSE B “Center of Inborn and Acquired Blood Diseases”, Freiburg Center of Rare Diseases |
| 2018-2024 | Head of the coordinating study center of EWOG-MDS/SAA |
| 2017-2024 | Attending physician, Division of Pediatric Hematology and Oncology Freiburg |
| 2013-2015 | Special training in pediatric hematology and oncology, Freiburg |
| 2006-2013 | Medical training in pediatrics and adolescent medicine, Freiburg |
| 2008-2024 | Physician scientist, group leader, Freiburg |
| 2021 | Venia Legendi in paediatrics, Faculty of Medicine, University of Freiburg |
| 2007 | PhD, Innsbruck Medical University, Austria (summa cum laude) |
| 2003 | Dr. med. univ. (MD), Leopold-Franzens University Innsbruck, Austria |